High-Risk Living Kidney Donors

Sam Kant; Dorry Segev; Nada Alachkar

doi:10.1007/978-3-031-09520-7_10

High-Risk Living Kidney Donors

Sam Kant, Dorry Segev, Nada Alachkar

School of Medicine

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

The rates of living kidney donation have been continually improving, yet only a small percentage of wait-listed patients receive a living donor kidney. As a result of advancements in various subspecialties in medicine, individuals that would have been considered ineligible for living donation, now represent a potential segment of the donor pool. In this chapter, we explore the advancements that have led to utilisation of organs from such donors with the high risk conditions such as human immunodeficiency virus (HIV), hepatitis B & C infection, previous malignancy, and elevated cardiometabolic risk, current experience and outcomes, along with risks associated with donation in this setting.

Original language	English (US)
Title of host publication	Living Kidney Donation
Subtitle of host publication	a Practical Guide
Publisher	Springer International Publishing
Pages	123-136
Number of pages	14
ISBN (Electronic)	9783031095207
ISBN (Print)	9783031095191
DOIs	https://doi.org/10.1007/978-3-031-09520-7_10
State	Published - Jan 1 2022

Keywords

Hepatitis B
Hepatitis C
High risk
HIV
Living kidney donors

ASJC Scopus subject areas

General Medicine

Access to Document

10.1007/978-3-031-09520-7_10

Cite this

@inbook{efc93472dbe146c0a4dc18038d44472c,

title = "High-Risk Living Kidney Donors",

abstract = "The rates of living kidney donation have been continually improving, yet only a small percentage of wait-listed patients receive a living donor kidney. As a result of advancements in various subspecialties in medicine, individuals that would have been considered ineligible for living donation, now represent a potential segment of the donor pool. In this chapter, we explore the advancements that have led to utilisation of organs from such donors with the high risk conditions such as human immunodeficiency virus (HIV), hepatitis B & C infection, previous malignancy, and elevated cardiometabolic risk, current experience and outcomes, along with risks associated with donation in this setting.",

keywords = "Hepatitis B, Hepatitis C, High risk, HIV, Living kidney donors",

author = "Sam Kant and Dorry Segev and Nada Alachkar",

note = "Publisher Copyright: {\textcopyright} Springer Nature Switzerland AG 2022.",

year = "2022",

month = jan,

day = "1",

doi = "10.1007/978-3-031-09520-7_10",

language = "English (US)",

isbn = "9783031095191",

pages = "123--136",

booktitle = "Living Kidney Donation",

publisher = "Springer International Publishing",

}

TY - CHAP

T1 - High-Risk Living Kidney Donors

AU - Kant, Sam

AU - Segev, Dorry

AU - Alachkar, Nada

N1 - Publisher Copyright: © Springer Nature Switzerland AG 2022.

PY - 2022/1/1

Y1 - 2022/1/1

N2 - The rates of living kidney donation have been continually improving, yet only a small percentage of wait-listed patients receive a living donor kidney. As a result of advancements in various subspecialties in medicine, individuals that would have been considered ineligible for living donation, now represent a potential segment of the donor pool. In this chapter, we explore the advancements that have led to utilisation of organs from such donors with the high risk conditions such as human immunodeficiency virus (HIV), hepatitis B & C infection, previous malignancy, and elevated cardiometabolic risk, current experience and outcomes, along with risks associated with donation in this setting.

AB - The rates of living kidney donation have been continually improving, yet only a small percentage of wait-listed patients receive a living donor kidney. As a result of advancements in various subspecialties in medicine, individuals that would have been considered ineligible for living donation, now represent a potential segment of the donor pool. In this chapter, we explore the advancements that have led to utilisation of organs from such donors with the high risk conditions such as human immunodeficiency virus (HIV), hepatitis B & C infection, previous malignancy, and elevated cardiometabolic risk, current experience and outcomes, along with risks associated with donation in this setting.

KW - Hepatitis B

KW - Hepatitis C

KW - High risk

KW - HIV

KW - Living kidney donors

UR - http://www.scopus.com/inward/record.url?scp=85164865942&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85164865942&partnerID=8YFLogxK

U2 - 10.1007/978-3-031-09520-7_10

DO - 10.1007/978-3-031-09520-7_10

M3 - Chapter

AN - SCOPUS:85164865942

SN - 9783031095191

SP - 123

EP - 136

BT - Living Kidney Donation

PB - Springer International Publishing

ER -

High-Risk Living Kidney Donors

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this